One Complex, One Star Compound, One Synonym
Silymarin, silybin, and silibinin are not three parallel ingredients — they’re a whole, a part, and a synonym. Silymarin is the complete standardized flavonolignan complex extracted from milk thistle seed. Silybin is the single most abundant compound within that complex, typically 50–60% of total content. Silibinin is not a different compound at all — it’s simply the name used for silybin in much of the European and clinical pharmaceutical literature. Understanding this relationship — and where the naming genuinely gets complicated — is what separates a correct COA reading from a costly sourcing mistake.
Silymarin: The Complex in Full
Silymarin is the sum of several related flavonolignans co-occurring in milk thistle seed, not a single molecule. Published pharmacological review places silybin at roughly 50–60% of total silymarin content, with silychristin contributing approximately 20%, silydianin approximately 10%, and isosilybin approximately 5% — the remainder made up of taxifolin, quercetin, and minor polyphenols.[1] This composition is why a “silymarin” specification and a “silybin” specification describe fundamentally different things: one is a fixed-ratio natural mixture, the other is a purified single-compound fraction pulled out of that mixture.
Silybin: Why It’s the Star Compound
Silybin earns its prominence honestly — it’s the most abundant flavonolignan in the complex and the most extensively studied. But “silybin” itself is not one molecule either: it’s a roughly 1:1 mixture of two diastereomers, silybin A and silybin B — stereoisomers that share the same molecular connectivity but differ in the three-dimensional arrangement at specific chiral centers.[2] The two are commonly distinguished by their optical rotation and have been characterized with defined absolute configurations at the relevant stereocenters.[3]
Silibinin = Silybin: Where the Naming Actually Comes From
Silibinin is not a separate compound — it is the same molecule as silybin, described under a different name that gained traction primarily in European and clinical pharmaceutical literature, while “silybin” is the more common designation in American commercial and research contexts.[3] This isn’t a case of two research communities discovering different things and giving them different names by coincidence — it reflects how the same compound moved through separate chemical and pharmaceutical naming traditions as research on it developed in parallel regions. Neither name is more “correct” or more authoritative than the other; both refer to the identical molecule.
In Chinese-language technical and commercial contexts, this naming overlap creates a documented, additional layer of confusion. Chinese chemical marketplace listings generally use distinct terms — 水飞蓟素 (silymarin, the complex) and 水飞蓟宾 (silybin/silibinin, the compound) — but cross-referencing errors do appear in practice: at least one commercial chemical supplier listing indexes silybin’s own CAS number (22888-70-6) while labeling its English name as “Silymarin” rather than “Silybin,” a mismatch that could lead a buyer to source the wrong specification entirely if the English label is trusted over the CAS number. The CAS number, not the English or Chinese name on a listing, is the specification detail that should always be independently verified.
Why the Market Sells These as “Three Products”
Commercial listings sometimes present “Silymarin extract,” “Silybin 98%,” and “Silibinin powder” as though they were three competing ingredient options — a framing that works commercially precisely because it isn’t obviously wrong to a buyer unfamiliar with the underlying chemistry. A practical rule for reading any listing using these names: check whether the stated percentage refers to the complex (silymarin, typically 30–80% depending on grade) or the single compound (silybin/silibinin, typically 70–98% HPLC) — these percentage ranges don’t overlap much, which makes them a useful sanity check on their own. A “silibinin 40%” listing, for instance, would be an unusually low purity for a purified single-compound fraction and is worth querying directly with the supplier before assuming it matches a standard silybin specification.
Valeherb supplies both Silymarin (standardized flavonolignan complex) and purified Silybin, with full UV and HPLC breakdown reported per batch. For the relationship between raw milk thistle seed extract and standardized Silymarin specifically, see our companion article, Milk Thistle Extract vs Silymarin: Is There a Difference? Full specifications are available on our bulk milk thistle extract product page.
Frequently Asked Questions
Is silybin the same as silymarin?
No — silymarin is the complete flavonolignan complex extracted from milk thistle seed, while silybin is a single compound within that complex, typically making up 50–60% of total silymarin content. A “silymarin” specification and a “silybin” specification are not interchangeable; they describe different purity levels of related but distinct raw materials.
Is silibinin the same as silybin?
Yes. Silibinin and silybin refer to the identical compound. Silibinin is the name more commonly used in European and clinical pharmaceutical literature, while silybin is the more common designation in American commercial and research contexts. Both terms refer to the same 1:1 mixture of silybin A and silybin B diastereomers.
What is the difference between silybin A and silybin B?
Silybin A and silybin B are diastereomers — they share the same molecular connectivity but differ in the three-dimensional arrangement at specific stereocenters, occurring naturally in roughly a 1:1 ratio. Notably, the specific “A” and “B” labels were reassigned in 2003 once researchers definitively determined each isomer’s absolute configuration, so some older literature may use the designation in reverse from current convention.
Why do some products say “silymarin” and others say “silybin” or “silibinin”?
This reflects a mix of genuine chemistry (silymarin is the complex, silybin/silibinin is the purified compound within it) and naming convention differences between American and European literature (silybin vs. silibinin for the same molecule). Some commercial listings also present these as though they were three separate products, which is why confirming the actual HPLC percentage and CAS number on a COA matters more than the label name alone.
References
[1] Gillessen A, Schmidt HH. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020;37(4):1279-1301. https://doi.org/10.1007/s12325-020-01251-y
[2] Biedermann D, Vavříková E, Cvak L, Křen V. Chemistry of silybin. Nat Prod Rep. 2014;31(9):1138-1157. https://doi.org/10.1039/C3NP70122K
[3] Njoroge JN, et al. Design, synthesis, and biological activity of conformationally restricted analogues of silibinin. ACS Omega. 2020;5(41):26777-26788. https://doi.org/10.1021/acsomega.0c02936
[4] Wu Y, et al. Determination of flavonolignan compositional ratios in Silybum marianum (milk thistle) extracts using high-performance liquid chromatography. Molecules. 2024;29(13):2949. PMC11243550
